
Bal Pharma (BALPHARMA) Share Price Rises 8.12% to Rs 113
Updated: 29 Sept 2026 • 2:55 pm
Posted by:

Bal Pharma Share Price is in focus today after the stock rose 8.12% to Rs 113, taking market capitalisation to Rs 171.79 crore. According to latest Univest data, the move is confirmed, but no company-specific catalyst is established. Bal Pharma Share Price Today therefore stands out as a price-rise event rather than a story built on an announced trigger.
The latest Univest figures show a day open of Rs 111.8, a high of Rs 114.5 and a low of Rs 105.32, which places the latest trade near the upper end of the day’s range. For readers following Bal Pharma Share Price Live, the immediate question is not only what moved, but how the current level fits into valuation, earnings and sector comparison. Univest data points to those areas as the main context for tracking Bal Pharma Stock News and Bal Pharma Share Price Update.
Bal Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 113 |
| Previous Close | Rs 104.51 |
| Today's Move | Rs 8.49 (+8.12%) |
| Open | Rs 111.8 |
| High | Rs 114.5 |
| Low | Rs 105.32 |
| Market Capitalisation | Rs 171.79 crore |
| Market Cap Category | Micro Cap |
Bal Pharma Ltd. (BALPHARMA) rose to Rs 113 from the previous close of Rs 104.51, a move of Rs 8.49 or 8.12%. The stock opened at Rs 111.8, reached a high of Rs 114.5, recorded a low of Rs 105.32.
The Bal Pharma Share Price Today move is a clear same-day gain, with the stock rising Rs 8.49 from the previous close of Rs 104.51 to Rs 113. The opening price was Rs 111.8, the day high was Rs 114.5 and the day low was Rs 105.32, so the stock traded with a wide intraday band and last traded close to the upper end of that range.
For Bal Pharma Share Price readers, that means the day’s price action is easy to verify in numbers and should be read as a share price rise rather than a broader conclusion about trend or conviction. The market capitalisation at Rs 171.79 crore keeps the company’s size visible alongside price action, and Bal Pharma Stock Performance can be tracked further through Univest without relying on any unverified reason. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes the next layer of Bal Pharma Share Price analysis a fundamental one.
Bal Pharma Ltd. (BALPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 171.79 crore |
| P/E Ratio | 23.08x |
| P/B Ratio | 2x |
| ROE | 7.92% |
| ROCE | 9.78% |
| EPS | Rs 4.53 |
| Book Value Per Share | Rs 52.36 |
| Dividend Yield | 1.15% |
Bal Pharma Ltd. (BALPHARMA) fundamental metrics show P/E 23.08x, P/B 2x, ROE 7.92%, ROCE 9.78%. These ratios show where the company stands today and are not a call to buy or sell.
Bal Pharma Ltd. has a market capitalisation of Rs 171.79 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 23.08x, P/B at 2x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.92% and ROCE of 9.78%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 4.53, book value per share of Rs 52.36, dividend yield of 1.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 23.08x |
| Benchmark Median P/E | 32.59x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 2x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 7.92% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 9.78% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 171.79 crore |
| Benchmark Median Market Cap | Rs 783.26 crore |
Bal Pharma Ltd. (BALPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Bal Pharma Ltd. (BALPHARMA) has a P/E ratio of 23.08x, which is below the benchmark median of 32.59x, a difference of -29.18%. A P/E difference of this kind is a reference point rather than a recommendation.
Bal Pharma Ltd. (BALPHARMA) has a ROE of 7.92%, which is below the benchmark median of 11.7%, a difference of -32.31%. Bal Pharma Ltd. (BALPHARMA) has a ROCE of 9.78%, which is below the benchmark median of 13.61%, a difference of -28.14%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 36.5 | 5.1 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,55,115.31 | 86.51 | 14.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,613.38 | 84.92 | 20.64 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,899.96 | 26.79 | 4.48 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
Bal Pharma Ltd. (BALPHARMA) has a P/E ratio of 23.08x compared with the displayed peer median of 36.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 7.92% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 9.78% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Bal Pharma Ltd. (BALPHARMA) has a market capitalisation of Rs 171.79 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Bal Pharma
- Bal Pharma Share Price is up 8.12% today, so the latest price action is the first point to monitor.
- The stock is trading at Rs 113 with a day high of Rs 114.5 and a day low of Rs 105.32, which gives clear intraday context.
- Bal Pharma Fundamental Analysis shows P/E of 23.08, P/B of 2 and EPS of 4.53, all worth tracking together.
- ROE of 7.92% and ROCE of 9.78% place Bal Pharma Share Price below the industry benchmark on operating-return measures.
- Healthcare sector comparison suggests Bal Pharma Share Price is lower on market capitalisation than the larger peer names tracked by Univest.
About Bal Pharma
Bal Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s listed identity on NSE and BSE places it within a broad Indian pharmaceutical universe where investors usually compare product businesses, earnings quality and valuation multiples. For Bal Pharma Share Price readers, the important point is that the company is being assessed through market capitalisation, earnings per share, book value, dividend yield and return ratios rather than any technical measure.
Bal Pharma Share Price also sits inside a sector where peer comparison matters because the industry includes much larger and much more richly valued names. That makes the company profile useful for readers who want a clean company overview before looking at Bal Pharma Stock News or Bal Pharma Share News. Univest frames the business as a listed pharmaceutical stock whose current relevance comes from price action, valuation and benchmark comparison.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Bal Pharma Share Price rising today?
Ans. Bal Pharma Share Price rose 8.12% to Rs 113 today. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. The previous close was Rs 104.51.
What is Bal Pharma Share Price today?
Ans. Bal Pharma Share Price today is Rs 113. The stock is up Rs 8.49 from the previous close of Rs 104.51, and market capitalisation stands at Rs 171.79 crore.
What is Bal Pharma Share Price Today move?
Ans. Bal Pharma Share Price Today shows an 8.12% rise. The stock traded between Rs 105.32 and Rs 114.5 during the day, with the latest trade near the upper end of that range.
Is Bal Pharma Share Price expensive on valuation?
Ans. Bal Pharma Share Price carries a P/E ratio of 23.08 and a P/B ratio of 2. Both sit below the same-industry median levels, which puts the valuation in a relatively lower band.
How does Bal Pharma compare with healthcare peers?
Ans. Bal Pharma Share Price has a lower market capitalisation than the larger peers tracked by Univest. Its P/E, ROE and ROCE also sit below several named healthcare companies in the comparison set.
What do EPS and book value say about Bal Pharma Share Price?
Ans. Bal Pharma Share Price is backed by EPS of 4.53 and book value of Rs 52.36. EPS shows earnings per share, while book value reflects the accounting net worth behind each share.
What does Bal Pharma dividend yield show?
Ans. Bal Pharma Share Price has a dividend yield of 1.15%. That figure reflects the historical payout relative to the current price and helps readers compare income characteristics with other listed pharmaceutical names.
Should investors track Bal Pharma Share Price on Univest?
Ans. Yes, Bal Pharma Share Price can be tracked on Univest for price updates, valuation ratios, market capitalisation and 52-week levels. It is useful when the stock is moving without a stated catalyst.
Track Bal Pharma Share Price on Univest
Use Bal Pharma Ltd. (BALPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Bal Pharma Share Price on Univest for live price updates, key fundamental ratios, 52-week levels and market insights. The platform keeps Bal Pharma Share Price, Bal Pharma Share Price Today and Bal Pharma Stock Analysis in one place so investors can follow the move alongside valuation and sector context.
That is useful when Bal Pharma Share Price rises without a stated catalyst, because Univest helps separate the day’s price action from the longer fundamental picture. For anyone checking Bal Pharma Latest News, Bal Pharma Stock News or Bal Pharma Share Price Live, the same page provides a compact view of the stock’s market cap, ratios and peer comparison.
Recent Articles

Cummins India Share Price Slips to Rs 4,005 Near Its 52-Week Low: Margins Squeezed by Commodity Costs While Price Hikes Take a Quarter to Flow Through
18 November 2026

V2 Retail Share Price Plunges 15% to a 52-Week Low of Rs 122.73 Then Rebounds to Close at Rs 141.61: What We Know, What We Do Not and the Numbers to Watch
18 November 2026

Infosys Share Price Falls to Rs 1,108.80, Down 25.4% in a Year: How India's IT Bellwether Lost a Quarter of Its Value and What Investors Should Check Next
18 November 2026

Nifty Bank 62,000: Index Closes at 62,038.65 After a Record 62,442.20, Up 24% From Its April Low as SBI Surges While HDFC Bank and Axis Bank Lag
18 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Cummins India Share Price Slips to Rs 4,005 Near Its 52-Week Low: Margins Squeezed by Commodity Costs While Price Hikes Take a Quarter to Flow Through
V2 Retail Share Price Plunges 15% to a 52-Week Low of Rs 122.73 Then Rebounds to Close at Rs 141.61: What We Know, What We Do Not and the Numbers to Watch
Infosys Share Price Falls to Rs 1,108.80, Down 25.4% in a Year: How India's IT Bellwether Lost a Quarter of Its Value and What Investors Should Check Next
Nifty Bank 62,000: Index Closes at 62,038.65 After a Record 62,442.20, Up 24% From Its April Low as SBI Surges While HDFC Bank and Axis Bank Lag
Mahanadi Coalfields IPO Opens 19 November: Rs 129 to Rs 136 Price Band, Rs 8,981 Crore Offer for Sale and a Coal India Unit Valued at About 8.4 Times Earnings

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





